Guttasil drops for oral administration 7.5 mg / ml fl. 30ml

Release form, composition and packaging

?

Drops for oral administration are clear, colorless or light yellow liquid.

1 ml (15 drops)

sodium picosulfate 7.5 mg

sorbitol - 460 mg, sodium methyl parahydroxybenzoate - 2.0 mg, 1M hydrochloric acid solution - up to pH 6.0-7.0, water d / i - up to 1 ml.

15 ml - polyethylene bottles with a dispenser and a lid (1) with a seal (control of the first opening) - cardboard packs.

30 ml - polyethylene bottles with a dispenser and a lid (1) with a seal (control of the first opening) - cardboard packs.

pharmachologic effect

Laxative.

Under the action of intestinal microorganisms, it is hydrolyzed to form an active form, which irritates the receptors of the intestinal mucosa and increases its peristalsis.

Pharmacokinetics

After oral administration, it is not absorbed from the gastrointestinal tract and does not undergo hepatic-intestinal circulation.

Indications for use

Constipation due to hypotension and sluggish peristalsis of the colon.

Stool regulation for hemorrhoids, proctitis, anal fissures.

Preparation for surgical operations, instrumental and X-ray examinations.

Contraindications for use

Intestinal obstruction, strangulated hernia, acute inflammatory diseases of the abdominal organs, peritonitis, abdominal pain of unknown origin, bleeding from the gastrointestinal tract, uterine bleeding, cystitis, spastic constipation, children under 4 years of age, I trimester of pregnancy, severe dehydration, hypersensitivity to sodium picosulfate.

Dosage regimen

Individual, depending on the patient's age and response to treatment.

It is taken orally before bedtime.

Side effect

Possibly: diarrhea, which can lead to excessive loss of fluid and electrolytes, weakness, seizures, arterial hypotension, and abdominal pain.

Drug interactions

With simultaneous use with broad-spectrum antibiotics, it is possible to reduce the laxative effect of sodium picosulfate.

With simultaneous use with diuretics, with GCS, an increase in the risk of electrolyte disturbances is possible.

The electrolyte imbalance that occurs while taking sodium picosulfate in high doses can lead to a deterioration in the tolerance of cardiac glycosides when used simultaneously.

Application during pregnancy and lactation

Contraindicated in the first trimester of pregnancy.

It should be used in the II and III trimester of pregnancy only if the intended benefit to the mother outweighs the possible risk to the fetus.

If necessary, use during lactation should stop breastfeeding.

Special instructions It has no taste, so children can add to food.

Do not use daily without medical supervision for more than 10 days.

Name ENG

GUTTALAX

Clinical and pharmacological group

Laxative drug that stimulates intestinal motility

ATX code

Sodium picosulfate

Dosage

7.5mg / ml x 30ml

Structure

1 ml contains: Active substance: sodium picosulfate monohydrate (in terms of sodium picosulfate) 7.5 mg

Excipients: sorbitol - 460 mg

sodium methyl parahydroxybenzoate - 2 mg

1M hydrochloric acid solution - up to pH 6–7

water for injection - up to 1 ml.

Indications

Constipation due to hypotension and sluggish peristalsis of the colon.

Stool regulation for hemorrhoids, proctitis, anal fissures.

Preparation for surgical operations, instrumental and X-ray examinations

Contraindications

Intestinal obstruction or obstructive bowel disease

- acute diseases of the abdominal organs or severe pain in the abdomen, which

may be accompanied by nausea, vomiting, fever, including

appendicitis

- acute inflammatory bowel disease

- hypersensitivity to sodium picosulfate or other components

drug

- severe dehydration

- lactase deficiency, lactose intolerance, glucose-galactose malabsorption

- children under 4 years old.

INN / Active ingredient

sodium picosulfate

Storage conditions and periods

At a temperature not exceeding 25 degrees, in the original packaging.

Expiration date: 3 years

Specifications

Category

Preparations for the gastrointestinal tract

,

Laxatives

Scope of the drug

Gastrointestinal tract

Release form

Drops

Manufacturer country

Ukraine

Package quantity, pcs

one

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Volume, ml.

30 ml

Brand name

Farmak

The amount of the dosage form in the primary package

30 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Laxative

Anatomical and therapeutic characteristics

A06AB08 Sodium picosulfate

Dosage form

Drops for oral administration

Dosage (volume) of the substance in the preparation

7.5 mg

The target audience

Children

Expiration date in days

1095

Package weight, g

45

Mode of application

:

Inside, at night (so that the stool was the next morning). < br> < br> The drug is dosed with the manufacturer's dispenser.

Adults and children over 10 years old - 13-27 drops (5-10 mg)

children from 4 to 10 years old - 7-13 drops (2.5-5 mg).

For children under 4 years of age, a dosage of 250 μg / kg (2 drops / 3 kg) is recommended.

For children, the drug can be added to food.

In children, a single dose of the drug is effective.

If necessary, the course of treatment for a child can be extended, but it is preferable to limit it to three days. < br> < br> To eliminate constipation in cancer patients receiving large doses of opioids, it is used as directed by a doctor.

Information on technical characteristics, delivery set, country of manufacture